Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bff1fc32f406950f0b8981fb5209e29f9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bff1fc32f406950f0b8981fb5209e29f9 NCIT_P378 "NCI" @default.
- Bff1fc32f406950f0b8981fb5209e29f9 type Axiom @default.
- Bff1fc32f406950f0b8981fb5209e29f9 annotatedProperty IAO_0000115 @default.
- Bff1fc32f406950f0b8981fb5209e29f9 annotatedSource NCIT_C180910 @default.
- Bff1fc32f406950f0b8981fb5209e29f9 annotatedTarget "A regimen consisting of lenvatinib and pembrolizumab that may be used for the treatment of cutaneous melanoma, hepatobiliary cancers, advanced endometrial carcinoma and advanced renal cell carcinoma (RCC)." @default.